TRLV · Trulieve Cannabis Corp.
$8.08
-0.26 (-3.06%)
At close · Jul 29
Market Cap
$1.55B
Shares
192.31M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.18B
-0.4%
FY2025
Net Income
-$122.25M
+23.9%
FY2025
Gross Margin
60.21%
-0.1pp
FY2025
Operating Margin
12.15%
+3.9pp
FY2025
Diluted EPS
-$0.58
+26.6%
FY2025
Operating Cash Flow
$272.82M
+0.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $1.17B | $1.18B | $1.19B | $1.13B | $1.22B | $931.93M | $521.53M | $252.82M | |
| $472.15M | $470.01M | $470.75M | $540.57M | $529.1M | $365.36M | $135.12M | $60.98M | |
| $698.03M | $711.17M | $715.75M | $588.63M | $689.13M | $566.57M | $386.42M | $191.84M | |
| — | 60.21% | 60.32% | 52.13% | 56.57% | 60.8% | 74.09% | 75.88% | |
| — | — | $257.72M | $240.17M | $277.56M | $211.91M | $119.4M | $59.35M | |
| — | — | $252.74M | $146M | $169.47M | $99.46M | $36.06M | $14.07M | |
| $431.34M | $445.21M | $510.45M | $386.16M | — | — | — | — | |
| — | $83.3M | $82.2M | $80.4M | $81.7M | $27.7M | $2.99M | $1.8M | |
| $118.05M | $117.63M | $112.81M | $109.83M | $116.38M | $45.79M | $12.6M | $5.08M | |
| $552.14M | $567.67M | $617.97M | $810.24M | $638.96M | $362.52M | $168.11M | $78.57M | |
| $145.89M | $143.5M | $97.78M | -$221.61M | $50.17M | $204.05M | $218.3M | $113.27M | |
| — | 12.15% | 8.24% | -19.63% | 4.12% | 21.9% | 41.86% | 44.8% | |
| $263.94M | $261.13M | $210.59M | -$111.79M | $166.55M | $249.84M | $230.9M | $118.35M | |
| $60.48M | $63.45M | $62.19M | $81.57M | $73.42M | $29.12M | $20.24M | $9.05M | |
| $10.96M | — | — | $6.16M | $1.63M | $205K | — | — | |
| -$49.53M | -$52.02M | -$55.07M | -$62.92M | -$69.4M | -$27.8M | -$60.85M | -$9.59M | |
| $96.37M | $91.47M | $42.71M | -$284.54M | -$19.24M | $176.25M | $157.45M | $103.68M | |
| $177.5M | $208.11M | $197.59M | $151.36M | $163.38M | $145.72M | $94.45M | $50.59M | |
| -$86.21M | -$122.25M | -$160.58M | -$533.14M | -$252.73M | $17.45M | $63M | $53.1M | |
| — | -10.35% | -13.53% | -47.21% | -20.75% | 1.87% | 12.08% | 21% | |
| — | -$5.87M | -$5.47M | -$5.15M | -$3.99M | -$587K | $0 | $0 | |
| -$81.11M | -$116.38M | -$155.11M | -$526.8M | -$246.06M | $18.03M | $63M | $53.1M | |
| USD/shares | — | -$0.58 | -$0.79 | -$2.28 | -$0.95 | $0.22 | $0.55 | $0.48 |
| USD/shares | — | -$0.58 | -$0.79 | -$2.28 | -$0.95 | $0.21 | $0.53 | $0.46 |
| shares | — | 191.32M | 189.99M | 188.97M | 188M | 139.37M | 113.57M | 110.21M |
| shares | — | 191.32M | 189.99M | 188.97M | 188M | 146.76M | 118.33M | 115.32M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.69×
EV/EBIT
—
Peer median 27.62×
P/E (TTM)
—
Peer median 20.56×
Peer medians compare against the 46 similar-size Drug Manufacturers - Specialty & Generic companies (of 91 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Retail | $1,110,437,000 | $1,128,877,000 | $1,083,545,000 | $1,158,475,000 | $869,707,000 | $520,217,000 |
| Wholesale and Other | $70,743,000 | $57,613,000 | $45,648,000 | $59,754,000 | — | — |
| Wholesale Licensing and Other | — | — | — | — | — | $1,316,000 |
| Wholesale | — | — | — | — | $61,137,000 | — |
| License | — | — | — | — | $1,090,000 | — |